High materiality8/10
Mirum Pharmaceuticals (MIRM) PT Raised to $144 at Citizens
Why it may matterVerify against the original reporting
bullish setup based on upside target
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Morgan Stanley raises MIRM's price target to $144 with a current price near $87.96, signaling strong upside potential and constructive sentiment around the stock.
- Morgan Stanley raises PT to $144; current price $87.96.
Key facts
- 01
Target: $144
- 02
Posted price: $87.96
- 03
Analyst firm: Morgan Stanley
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.